Abstract
The fallopian tube, connecting the uterus with the ovary, is a dynamic organ that undergoes cyclical changes and is the site of several diseases, including serous cancer. Here, we use single-cell technologies to construct a comprehensive cell map of healthy pre-menopausal fallopian tubes, capturing the impact of the menstrual cycle and menopause on different fallopian tube cells at the molecular level. The comparative analysis between pre- and post-menopausal fallopian tubes reveals substantial shifts in cellular abundance and gene expression patterns, highlighting the physiological changes associated with menopause. Further investigations into menstrual cycle phases illuminate distinct molecular states in secretory epithelial cells caused by hormonal fluctuations. The markers we identified characterizing secretory epithelial cells provide a valuable tool for classifying ovarian cancer subtypes.
Graphical summary Graphical summary of results. During the proliferative phase (estrogenhigh) of the menstrual cycle, SE2 cells (OVGP1+) dominate the fallopian tube (FT) epithelium, while SE1 cells (OVGP1-) dominate the epithelium during the secretory phase. Though estrogen levels decrease during menopause, SE post-cells (OVGP1+, CXCL2+) make up most of the FT epithelium.
Competing Interest Statement
E.L. receives research funding to study ovarian cancer from Arsenal Bioscience and AbbVie through the University of Chicago unrelated to this work. All other authors declare no other competing interest.
Funding Statement
We thank the women who donated the tissues and the surgeons that helped make this study possible. We also thank the Human Tissue Resource Center, the Genomics Facility, and the patients that kindly donated tissues for this study. Grant funding: This work is supported by the Chan Zuckerberg Initiative (to E.L., O.B., M.W., M.C.). M.C. is supported by the NIH (R01 GM126553 and R01 HG011883), the National Science Foundation (NSF 2016307), and the Sloan Research Fellowship Program. A.B. is supported by NIH DP2AI158157. E.L. is supported by R35CA264619, RO1CA211916, RO1CA237029, the Ovarian Cancer Research Alliance (OCRA), and Bears Care the charitable beneficiary of the Chicago Bears Football Club.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All procedures were conducted under the approval of the institutional Review Board at the University of Chicago.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
De-identified human single-cell RNA and ATAC sequencing data have been deposited at CELLxGENE and at the European Genome-Phenome Archive (EGA). They are publicly available as of the date of publication. The link to the data is listed in the key resource table.
Abbreviations
- A
- ampulla
- B/P
- B and plasma B cells
- CE
- ciliated epithelial cells
- EMT
- epithelial to mesenchymal transition
- EN
- endothelial cells
- F
- fimbriae
- FT
- fallopian tube
- FTEC
- fallopian tube epithelial cells
- FTSC
- fallopian tube stromal cells
- GWAS
- genome-wide association studies
- H&E
- hematoxylin and eosin
- HGSC
- high-grade serous cancer
- I
- isthmus
- IM
- immune cells
- LE
- lymphatic endothelial cells
- MA
- mast cells
- MN
- monocytes
- MP
- macrophages
- P/V
- pericytes and vascular smooth muscle cells
- scRNA-seq
- single-cell RNA sequencing
- scATAC-seq
- single-cell assay on transposase-accessible chromatin
- SE
- secretory epithelial cells
- SM
- smooth muscle cells
- ST
- stromal cells
- TCGA
- The Cancer Genome Atlas
- T/NK
- T and NK cells
- TF
- transcription factors
- SASP
- senescence-associated secretory phenotype
